Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Are the chimpanzees safe from newly discovered pathogens?

Detection of two new Covid-19 diagnostic tests

Govt HPCL R&D Officer With Rs. 1.8 Lakh pm Salary | Apply Online

Are the chimpanzees safe from newly discovered pathogens?
  • BiotechToday
  • World

Are the chimpanzees safe from newly discovered pathogens?

bioxone March 7, 2021March 7, 2021

-Souradip Mallick, National Institute of Technology, Rourkela

Tacugama in Sierra Leone is the sanctuary for western chimpanzees, a critically endangered subspecies. This sanctuary is the hub of environmental education, ecotourism, and community conservation projects. Ninety-nine chimps permanently reside at Tacugama today. Among them, many of them were rescued as babies from the illegal wildlife trade.

In 2005 many chimps died with epizootic neurologic and gastroenteric syndrome (ENGS). The syndrome varies with some showing neurological signs such as lack of coordination and seizures, and others suffering from gastrointestinal distress—or even both. Even if they recover from ENGS, they only succumb weeks or months, and then died without any warning signs. At that time veterinarians predict some virus attack so they vaccinated every chimp in the sanctuary, treat ill chimps with antibiotics and fluids. But cases kept coming, almost 53 perished between 2005 and 2018.

In 2016 Pan African Sanctuary Alliance, an umbrella organization for the continent’s primate sanctuaries took this matter seriously and discussed this with epidemiologist Tony Goldberg, Owens’ advisor at the University of Wisconsin–Madison. After two and a half years in 2019, the Wisconsin researchers obtained tissue, blood, serum, and fecal samples from 13 chimps that had died of the syndrome and 14 healthy ones. Owens, Goldberg, and their colleagues performed a comprehensive analysis on the samples to characterize all of the viruses, bacteria, and parasites present. Diagnostic sequencing and statistical analyses confirmed that it was the bacterium who is the main causative agent, and this bacterium was not present in any of the healthy chimps, suggesting a link to ENGS.

The causative microbe seemed to be Sarcina ventriculi, which looks like a four-leaf clover and is ubiquitous in water and soil around the world. The species was first discovered in a 19th-century human patient who presented with vomiting, but it then largely disappeared from the scientific literature related to the disease. After genome sequencing, it was revealed that it was unknown Sarcina species, which they named Sarcina troglodytae, and under a microscope, it looks like a cubic structure. It is not clear to them whether it was an emerging new pathogen or Sarcina modified itself, but it is more virulent than Sarcina ventriculi.

Owens and Goldberg hypothesized that there is a diversity of unrecognized Sarcina species, some of which are benign and some of which are opportunistic pathogens. 

The most important question now is how to treat them. Veterinarians are changing their approach to treatment. They give sick chimps antacids, anticonvulsive, antibiotics, probiotics, and a special diet, similar to that of the human. 

Source: Ann Gibbons; “A mysterious disease is killing chimps in West Africa. Scientists may now know the culprit”; Feb. 3, 2021; sciencemag.org;AfricaPlants & Animals; doi:10.1126/science.abg8897

For more articles visit bioXone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ENGS gastrointestinal distress genome sequencing opportunistic pathogens probiotics Sarcina troglodytae Sarcina ventriculi

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Govt HPCL R&D Officer With Rs. 1.8 Lakh pm Salary | Apply Online

bioxone March 7, 2021

-Shristi Sharma, Team bioXone HPCL Officer Recruitment With Up to Rs. 2 Lakh Salary pm. HP Green R&D Centre 2021 Recruitment for Ph.D. candidates. FRESHERS CAN ALSO APPLY. Latest Hindustan Petroleum Corporation Limited (HPCL) Jobs. Check out all of the details on the same below: HINDUSTAN PETROLEUM CORPORATION LIMITED Regd. Office: 17, Jamshedji Tata Road, […]

Related Post

  • BiotechToday
  • World

NEW INSIGHTS INTO MALARIA VECTOR IN LAOS COUNTRY

bioxone October 19, 2020October 18, 2020

Aishila Kar, Amity University Kolkata Malaria is the deadliest vector-borne disease worldwide with an average of 228 million cases, and 405,000 deaths in 2018, mainly in the African Region (93%), and the South-East Asia Region (3.4%). In Laos, the malaria burden remains despite a significant reduction of cases during the last decade. In the condition […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Complement Tissue injury and its protection during COVID-19

bioxone October 7, 2020October 7, 2020

Srilagna Sarkar, Amity University Kolkata Even though the novel coronavirus disease originates in the lungs, it may extend to other tissues and cause organ damage including cardiac injury, multiorgan failure, and even acute kidney injury, associating it with an increased risk of death. Although the COVID-19 tissue injury is not primarily mediated by any viral […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients

bioxone October 1, 2020October 1, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA BET (Bromodomain and extra terminal domain) proteins are described to be epigenetic and anti-cancer drug targets. This was the first-in-human study that judged the pharmacokinetics and prior activity of ODM-20, the inhibitor of BET in patients having solid tumours.  The main objective was to determine the tolerability, dose-limiting toxicities (DLT), […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy